Thomas V Johnson, DPM | |
1379 Enfield St, Enfield, CT 06082-5524 | |
(860) 741-3041 | |
(860) 741-5644 |
Full Name | Thomas V Johnson |
---|---|
Gender | Male |
Speciality | Podiatrist - Foot & Ankle Surgery |
Location | 1379 Enfield St, Enfield, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932179421 | NPI | - | NPPES |
0V0651 | Other | HEALTHNET | |
030000373CT02 | Other | ANTHEM | |
HAS372 | Other | OXFORD | |
0453607-001 | Other | CIGNA | |
4138298 | Other | AETNA | |
CT0005060 | Other | TRICARE | |
060373 | Other | CONNECTICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | P00373 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Thomas V Johnson, DPM 1379 Enfield St, Enfield, CT 06082-5524 Ph: (860) 741-3041 | Thomas V Johnson, DPM 1379 Enfield St, Enfield, CT 06082-5524 Ph: (860) 741-3041 |
News Archive
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
There's no denying that people need calcium for strong, healthy bones. But new research from North Carolina State University suggests that not getting enough calcium in the earliest days of life could have a more profound, lifelong impact on bone health and perhaps even obesity than previously thought.
Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.
Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.
Doctors can't predict who will develop Type 1 diabetes, a chronic autoimmune disease in which one's own immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.
› Verified 1 days ago
Rebecca Wiesner, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Enfield St, Enfield, CT 06082 Phone: 860-741-3041 Fax: 860-741-5644 | |
Podiatrycare P C Podiatrist Medicare: Medicare Enrolled Practice Location: 1379 Enfield St, Enfield, CT 06082 Phone: 860-741-3041 Fax: 860-741-5644 | |
Charlotte George, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Enfield St, Enfield, CT 06082 Phone: 860-741-3041 Fax: 860-741-5644 | |
Dr. Edwin Steven Damon, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 64 Palomba Dr, Enfield, CT 06082 Phone: 860-745-6248 Fax: 860-741-2482 | |
Laura C Vander Poel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Enfield Street, Enfield, CT 06082 Phone: 860-741-3041 | |
Kristen E Winters, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1379 Enfield St, Enfield, CT 06082 Phone: 860-741-3041 Fax: 860-741-5644 | |
E Steven Damon, D.p.m. Podiatrist Medicare: Medicare Enrolled Practice Location: 64 Palomba Dr, Enfield, CT 06082 Phone: 860-745-6248 Fax: 860-741-2482 |